Duke Conte Center for the Neuroscience of Depression in Late Life

Major Depression Clinical Trial

Official title:

Conte Centers for the Neuroscience of Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00576875
• Other study ID #: Pro00007678
• Status: Completed
• Phase: N/A
• First received: December 18, 2007
• Last updated: February 20, 2012
• Start date: August 2006
• Est. completion date: July 2011

Study information

• Verified date: February 2012
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The proposed Silvio O. Conte Center for Neuroscience of Depression will focus on understanding the neurobiological mechanism of depression. A total of 5 projects are proposed. The center is focused on a single hypothesis. The first project examines localization of lesions, structural changes in critical regions subserving the circuit, alterations in the white matter tracts relevant to the circuit and changes in glutamate. The second project uses post mortem cell counting and cellular localization in serotonin receptors and assessment of the type of cell loss in the orbitofrontal cortex. The third project uses cognitive paradigms and functional MRI to probe the circuit and the role of brain lesions and serotonin on the functioning of this circuit. The fourth project uses transgenic and knockout mice to examine to role of norepinephrine and serotonin as it relates to the circuit. The final project is designed to assess in these transgenic mice using multielectrode array of single neuron recordings of the firing pattern of the circuit neurons in various states and tasks and the role of monoamines in modulating this circuit.

Description:

Three shared resources, administrative, research and assessment and data management/statistics are proposed to facilitate the conduct of these projects and to ensure integration at the conceptual, analytical and resource availability level, and flow to the various projects. Findings from the center should greatly enhance our understanding of the biology of depressive disorders and help improve the treatment of these disorders. In addition, the technological innovations developed in the context of this project are likely to be of major importance and relevant to other studies of brain function.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 795
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

For depressed group:

1. Age > 60 years

2. Major depression, single episode or recurrent

3. Ability to read and write English

4. MMSE >25

5. Willingness to participate in the follow-up study for at least two years.

For non-depressed group:

1. Age > 60 years

2. Ability to read and write English

3. MMSE >25

4. Willingness to participate in the follow-up study for at least two years

Exclusion Criteria:

1. Lifetime alcohol or drug dependence

2. Conditions associated with MRI abnormalities such hydrocephalus, benign and cancerous brain tumors, epilepsy, Parkinson's disease, Huntington's chorea, dementia, demyelinating diseases, etc.

3. Endocrine disorder (other than diabetes mellitus)

4. Any physical or intellectual disability that may affect completion of self rating instruments

5. Established clinical diagnosis of dementia

6. Other primary psychiatric disorders, including panic disorder, social phobia, OCD, non-affective psychosis (including schizo-affective disorder), schizophrenia, bipolar disorder

7. Any metal or pacemaker in the body which precludes MRI.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Depressive Disorder, Major
• Major Depression

Locations

Country	Name	City	State
United States	Duke University Medical Center	Durham	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	University of Mississippi Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Each of the projects in the Duke Conte Center has its own aims and primary outcomes		Up to five years	No